Essential fatty acids and attention-deficit–hyperactivity disorder: a systematic review
Raz R et al. - Children with ADHD present lower levels of blood EFAs, and open-label EFA supplementation trials in ADHD raise EFA blood levels and improve symptoms of ADHD. Randomized controlled trials, however, have generally been unsuccessful in demonstrating any behavioural treatment effects. Current findings do not support the use of EFA supplements as a primary or supplementary treatment for children with ADHD. [more...]
|
|
|
